Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 584

1.

miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.

Li LZ, Zhang CZ, Liu LL, Yi C, Lu SX, Zhou X, Zhang ZJ, Peng YH, Yang YZ, Yun JP.

Carcinogenesis. 2014 Feb;35(2):469-78. doi: 10.1093/carcin/bgt330. Epub 2013 Oct 1.

PMID:
24085799
2.

MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.

Dong P, Kaneuchi M, Watari H, Sudo S, Sakuragi N.

Mol Carcinog. 2014 May;53(5):349-59. doi: 10.1002/mc.21983. Epub 2013 Sep 3.

PMID:
24002805
3.

Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.

Khan MA, Tania M, Wei C, Mei Z, Fu S, Cheng J, Xu J, Fu J.

Oncotarget. 2015 Aug 14;6(23):19580-91.

4.

miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.

Yu J, Xie F, Bao X, Chen W, Xu Q.

Mol Cancer. 2014 May 24;13:121. doi: 10.1186/1476-4598-13-121.

5.

Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.

Wei L, Sun JJ, Cui YC, Jiang SL, Wang XW, Lv LY, Xie L, Song XR.

Tumour Biol. 2016 Jul;37(7):9979-87. doi: 10.1007/s13277-016-4896-2. Epub 2016 Jan 27.

PMID:
26819207
6.

MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin.

Zhang N, Wang X, Huo Q, Sun M, Cai C, Liu Z, Hu G, Yang Q.

Oncogene. 2014 Jun 12;33(24):3119-28. doi: 10.1038/onc.2013.286. Epub 2013 Jul 15.

PMID:
23851509
7.

TWIST1 expression in breast cancer cells facilitates bone metastasis formation.

Croset M, Goehrig D, Frackowiak A, Bonnelye E, Ansieau S, Puisieux A, Clézardin P.

J Bone Miner Res. 2014 Aug;29(8):1886-99. doi: 10.1002/jbmr.2215.

8.

MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231.

Zhao X, Duan Z, Liu X, Wang B, Wang X, He J, Yao Z, Yang J.

Anat Rec (Hoboken). 2013 Dec;296(12):1842-9. doi: 10.1002/ar.22823. Epub 2013 Oct 24.

9.

Cordycepin (3'-deoxyadenosine) suppressed HMGA2, Twist1 and ZEB1-dependent melanoma invasion and metastasis by targeting miR-33b.

Zhang P, Huang C, Fu C, Tian Y, Hu Y, Wang B, Strasner A, Song Y, Song E.

Oncotarget. 2015;6(12):9834-53.

10.

MicroRNA-361-5p inhibits epithelial-to-mesenchymal transition of glioma cells through targeting Twist1.

Zhang X, Wei C, Li J, Liu J, Qu J.

Oncol Rep. 2017 Mar;37(3):1849-1856. doi: 10.3892/or.2017.5406. Epub 2017 Jan 25.

PMID:
28184914
11.

MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.

Zheng M, Sun X, Li Y, Zuo W.

Tumour Biol. 2016 Jun;37(6):8189-96. doi: 10.1007/s13277-015-4722-2. Epub 2015 Dec 29.

PMID:
26715279
12.

miR-134 suppresses the migration and invasion of non‑small cell lung cancer by targeting ITGB1.

Qin Q, Wei F, Zhang J, Li B.

Oncol Rep. 2017 Feb;37(2):823-830. doi: 10.3892/or.2017.5350. Epub 2017 Jan 3.

PMID:
28075475
13.

MiR-137 regulates epithelial-mesenchymal transition in gastrointestinal stromal tumor.

Liu S, Cui J, Liao G, Zhang Y, Ye K, Lu T, Qi J, Wan G.

Tumour Biol. 2014 Sep;35(9):9131-8. doi: 10.1007/s13277-014-2177-5. Epub 2014 Jun 12.

PMID:
25027394
15.

miR-151-3p Targets TWIST1 to Repress Migration of Human Breast Cancer Cells.

Yeh TC, Huang TT, Yeh TS, Chen YR, Hsu KW, Yin PH, Lee HC, Tseng LM.

PLoS One. 2016 Dec 8;11(12):e0168171. doi: 10.1371/journal.pone.0168171. eCollection 2016.

16.

CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.

Lee KW, Sung CO, Kim JH, Kang M, Yoo HY, Kim HH, Um SH, Kim SH.

Int J Cancer. 2015 Jan 15;136(2):310-21. doi: 10.1002/ijc.29006. Epub 2014 Jun 26.

17.

microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway.

Liu C, Yang H, Xu Z, Li D, Zhou M, Xiao K, Shi Z, Zhu L, Yang L, Zhou R.

J Cancer Res Clin Oncol. 2015 Mar;141(3):431-41. doi: 10.1007/s00432-014-1836-7. Epub 2014 Sep 23.

PMID:
25245053
18.
19.

MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer.

Chen D, Dang BL, Huang JZ, Chen M, Wu D, Xu ML, Li R, Yan GR.

Oncotarget. 2015 Oct 20;6(32):32701-12. doi: 10.18632/oncotarget.4702.

20.

AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.

Shi Z, Zhang J, Qian X, Han L, Zhang K, Chen L, Liu J, Ren Y, Yang M, Zhang A, Pu P, Kang C.

Cancer Res. 2013 Sep 1;73(17):5519-31. doi: 10.1158/0008-5472.CAN-13-0280. Epub 2013 Jun 28.

Supplemental Content

Support Center